Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan vs Losartan in Essential Hypertension
NCT00856271Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2004
- Primary completion
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olmesartan in essential hypertension, sponsored by Daiichi Sankyo Co., Ltd.. Started Aug 2004; status: completed.
02
Drugs
olmesartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00856271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00856271.